The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older patients with cancer
about
Management of pancreatic cancer in the elderlyAdjuvant treatment for older women with invasive breast cancerPhysical performance measures for predicting outcome in cancer patients: a systematic review.Decision-making in geriatric oncology: systemic treatment considerations for older adults with colon cancer.The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional studyFrailty and elderly in urology: Is there an impact on post-operative complications?Optimal management of elderly cancer patients: usefulness of the Comprehensive Geriatric Assessment.Exclusion of older patients from ongoing clinical trials for hematological malignancies: an evaluation of the National Institutes of Health Clinical Trial Registry.Frailty is an independent predictor of survival in older patients with colorectal cancer.The prevalence and outcomes of frailty in older cancer patients: a systematic review.The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people.Vulnerability in elderly patients with gastrointestinal cancer--translation, cultural adaptation and validation of the European Portuguese version of the Vulnerable Elders Survey (VES-13).To Operate or Not: Prediction of 3-Month Postoperative Mortality in Geriatric Cancer Patients.Impact of Comorbidity and Age on Determinants Therapeutic Strategies in Advanced Pancreatic Head Cancer Patients With Obstructive JaundicesThe effect of a geriatric evaluation on treatment decisions for older cancer patients--a systematic review.Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013.Geriatric assessment factors are associated with mortality after hospitalization in older adults with cancer.Motivation and mortality in older women with early stage breast cancer: A longitudinal study with ten years of follow-up.Diagnostic performance of gait speed, G8 and G8 modified indices to screen for vulnerability in older cancer patients: the prospective PF-EC cohort study.Screening for Frailty in Older Patients With Early-Stage Solid Tumors: A Prospective Longitudinal Evaluation of Three Different Geriatric Tools.Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia: Results of the CLL9 trial of the German CLL study group.Comprehensive Geriatric Assessment and predicted 3-year survival in treatment planning for frail patients with early breast cancer.Multimodal therapy is feasible in elderly anal cancer patients.Risk factors for unplanned discontinuation of scheduled treatment in elderly patients with castration-resistant prostate cancer: results of the IBuTu study.The value of physical performance measurements alongside assessment of sarcopenia in predicting receipt and completion of planned treatment in non-small cell lung cancer: an observational exploratory study.Carboplatin plus weekly nanoparticle albumin-bound paclitaxel in elderly patients with previously untreated advanced squamous non-small-cell lung cancer selected based on Mini Nutritional Assessment short-form scores: a multicenter phase 2 study.How do oncologists make decisions about chemotherapy for their older patients with cancer? A survey of Australian oncologists.Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) Task Force.What Every Oncologist Should Know About Geriatric Assessment for Older Patients With Cancer: Young International Society of Geriatric Oncology Position Paper.The G8 screening tool detects relevant geriatric impairments and predicts survival in elderly patients with a haematological malignancy.
P2860
Q26774639-23D1749E-F960-410E-96A7-883E354E9A4AQ28066744-A40DD166-5BAB-40AC-B47F-C775F8132FEBQ30244765-A6191C54-AE54-406C-930F-A5D465A62A9AQ30244769-4C0CEBDA-BDD6-427E-931D-BC589D097405Q33825402-D0924825-FE09-4187-9CEF-17DA2BAB2CC9Q33904104-74DD21AF-CB94-448D-A657-959F1C6A0476Q34306560-7A18A32F-5001-4BEA-A79C-F42BE3B18A5CQ34359352-A509CF37-736F-4A04-B27F-EF3683347F47Q34641057-2081DEB7-FEB8-4DAF-8317-4CBEB051164EQ35430157-6C5E1A81-29C6-4359-9430-8B8DCA405181Q35677917-57121680-5DCF-42F7-AD85-AD5D16F47D96Q35811197-7A420D06-EAE3-4BAE-AA21-54E64F3A87E4Q35882973-90872C00-CADE-4B0B-84F6-228579130C4DQ36194616-6C1ADEF0-7FA1-4A40-B93B-2CF2C9444FD2Q38153455-B9BA7110-942E-4070-9DFC-5E598952B2EAQ38228522-88779928-A966-49F1-A788-EFE4C0DD1F1BQ38910410-103C7AAD-285C-45AE-AA95-9A94C33544B7Q39093776-E23712A0-3250-454D-A412-E17C6C6617A7Q40053330-D8E13229-6552-43E8-9833-DE0DBB38B938Q40351383-B776C372-4BFB-4F1B-ABB7-6CDD37EB18C4Q41351036-2767D562-F1AA-4DBF-867E-D4A6926CD5F5Q41362832-A9457D1C-18F6-476F-8C69-63291DF599C9Q42501308-E807556F-38B1-46C0-B986-CB17B50EAC96Q47558914-7D9E0800-05E1-449C-999F-8C064C5E51D9Q47828833-8AD9A854-7482-4750-B8F6-87AC9D889885Q47839818-F6770AE2-DA18-4D15-ADE4-F18CCA97D89BQ48293280-FD0251A8-D249-4F09-B1E3-D19FFD39D10DQ48751476-A8C800E2-91E1-4704-8886-143262E08E74Q50045189-AE1F9774-B794-4B12-9899-3C79CBC76C66Q50726698-71FF4A6F-7B28-4EC4-9484-A6A3FBDC07B7
P2860
The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older patients with cancer
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The value of geriatric assessm ...... in older patients with cancer
@ast
The value of geriatric assessm ...... in older patients with cancer
@en
type
label
The value of geriatric assessm ...... in older patients with cancer
@ast
The value of geriatric assessm ...... in older patients with cancer
@en
prefLabel
The value of geriatric assessm ...... in older patients with cancer
@ast
The value of geriatric assessm ...... in older patients with cancer
@en
P2093
P2860
P1433
P1476
The value of geriatric assessm ...... in older patients with cancer
@en
P2093
Barbara C van Munster
Carolien H Smorenburg
Marije E Hamaker
Sophia E de Rooij
P2860
P304
P356
10.1634/THEONCOLOGIST.2012-0186
P50
P577
2012-08-31T00:00:00Z